Correlation Between Ikena Oncology and Dyadic International
Can any of the company-specific risk be diversified away by investing in both Ikena Oncology and Dyadic International at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ikena Oncology and Dyadic International into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ikena Oncology and Dyadic International, you can compare the effects of market volatilities on Ikena Oncology and Dyadic International and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ikena Oncology with a short position of Dyadic International. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ikena Oncology and Dyadic International.
Diversification Opportunities for Ikena Oncology and Dyadic International
0.15 | Correlation Coefficient |
Average diversification
The 3 months correlation between Ikena and Dyadic is 0.15. Overlapping area represents the amount of risk that can be diversified away by holding Ikena Oncology and Dyadic International in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dyadic International and Ikena Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ikena Oncology are associated (or correlated) with Dyadic International. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dyadic International has no effect on the direction of Ikena Oncology i.e., Ikena Oncology and Dyadic International go up and down completely randomly.
Pair Corralation between Ikena Oncology and Dyadic International
Given the investment horizon of 90 days Ikena Oncology is expected to generate 301.98 times less return on investment than Dyadic International. But when comparing it to its historical volatility, Ikena Oncology is 4.86 times less risky than Dyadic International. It trades about 0.01 of its potential returns per unit of risk. Dyadic International is currently generating about 0.4 of returns per unit of risk over similar time horizon. If you would invest 111.00 in Dyadic International on August 25, 2024 and sell it today you would earn a total of 82.00 from holding Dyadic International or generate 73.87% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Ikena Oncology vs. Dyadic International
Performance |
| Timeline |
| Ikena Oncology |
| Dyadic International |
Ikena Oncology and Dyadic International Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Ikena Oncology and Dyadic International
The main advantage of trading using opposite Ikena Oncology and Dyadic International positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ikena Oncology position performs unexpectedly, Dyadic International can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dyadic International will offset losses from the drop in Dyadic International's long position.| Ikena Oncology vs. Eliem Therapeutics | Ikena Oncology vs. HCW Biologics | Ikena Oncology vs. RenovoRx | Ikena Oncology vs. Scpharmaceuticals |
| Dyadic International vs. Eliem Therapeutics | Dyadic International vs. HCW Biologics | Dyadic International vs. RenovoRx | Dyadic International vs. Scpharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Global Correlations Find global opportunities by holding instruments from different markets |